Cargando…
Endogenous interleukin-22 prevents cardiac rupture after myocardial infarction in mice
Myocardial infarction (MI) can result in fatal myocardial rupture or heart failure due to adverse remodeling and dysfunction of the left ventricle. Although recent studies have shown that exogenous interleukin (IL)-22 shows cardioprotective effect after MI, the pathophysiological significance of end...
Autores principales: | Yamamoto, Mai, Yasukawa, Hideo, Takahashi, Jinya, Nohara, Shoichiro, Sasaki, Tomoko, Shibao, Kodai, Akagaki, Daiki, Okabe, Kota, Yanai, Toshiyuki, Shibata, Tatsuhiro, Fukumoto, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270598/ https://www.ncbi.nlm.nih.gov/pubmed/37319277 http://dx.doi.org/10.1371/journal.pone.0286907 |
Ejemplares similares
-
SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury
por: Nohara, Shoichiro, et al.
Publicado: (2021) -
Interleukin‐22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription‐3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury
por: Takahashi, Jinya, et al.
Publicado: (2020) -
Multidisciplinary Team-Based Palliative Care for Heart Failure and Food Intake at the End of Life
por: Shibata, Tatsuhiro, et al.
Publicado: (2021) -
Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules
por: Nagata, Takanobu, et al.
Publicado: (2015) -
Risk factor structure of heart failure in patients with cancer after treatment with anticancer agents’ assessment by big data from a Japanese electronic health record
por: Nohara, Shoichiro, et al.
Publicado: (2023)